Pulling SEC filings + quote and writing the call…

NATURAL HEALTH TRENDS CORP
Next earnings Jul 28, 2026
Last earnings -0.7% on 2026-04-29
A melting-ice-cube direct seller: statistically cheap but shrinking, cash-burning, and paying a dividend it can no longer afford.
Revenue $39.8M · FY2025
NHT Global is in a multi-year secular decline dressed up as a value stock. Revenue has fallen every year from $60.0M (FY2021) to $39.8M (FY2025, -7.4% YoY), and FY2025 finally tipped into a net loss of -$882K with a -$1.81M operating loss — the first red ink after four profitable years. The MD&A names the cause plainly: active members dropped to 26,650 from 30,870 (down ~14%), and the company itself flags 'our continuing loss of a significant number of members is adversely affecting our business.' A 73.5% gross margin can't save a shrinking top line when the sales force is eroding.
The balance sheet looks superficially safe — $23.4M equity, no meaningful debt (liabilities/equity 0.64x), current assets $34.2M vs. $13.7M current liabilities — but the cash statement tells the real story. Operating cash flow swung to -$6.00M (down 78% YoY) and cash was cut roughly in half to $6.81M. Then the Feb 2026 subsequent event drained it further: the company bought back the founder Broady family trusts' 2,935,227 shares (25.5% of the company) at $2.00 for ~$5.9M in cash 'from existing cash on hand,' leaving well under $1M of the reported year-end balance behind a business that is still burning. Meanwhile it paid $9.21M in dividends in FY2025 — more than half the entire $15.7M market cap — against negative earnings. That dividend is mathematically unsustainable and, in my view, the most likely thing to be cut.
Is NHTC a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $60.0M | $49.1M | $43.9M | $43.0M | $39.8M |
| Gross profit | $45.0M | $36.5M | $32.7M | $31.8M | $29.3M |
| Operating income | $1.57M | -$270K | -$1.67M | -$1.30M | -$1.81M |
| Net income | $1.08M | $313K | $568K | $572K | -$882K |
| Diluted EPS | $0.09 | $0.03 | $0.05 | $0.05 | -$0.08 |
| Net margin | 1.8% | 0.6% | 1.3% | 1.3% | -2.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results; board/officer change reported (items 5.02, 5.07)
Q1 2026 10-Q: revenue pressure persists after FY2025 loss
Q1 2026 10-Q: revenue pressure persists after FY2025 loss
2026 proxy (duplicate): annual meeting governance and comp items
2026 proxy (duplicate): annual meeting governance and comp items
FY2025 10-K: first net loss (-$882K), active members 26,650 vs 30,870
Signed $5.9M deal to buy back 25.5% of shares from Broady trusts at $2.00
Q4/FY2025 results: swung to a net loss; revenue -7.4% YoY
Q3 2025 10-Q: revenue and member counts continue to erode
Sources: SEC EDGAR (CIK 0000912061, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 7/4/2026, 5:10:35 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:10 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2024-12-15 | MASON RANDALL A Director | Exercise | 1.66K | |
| 2024-12-15 | MASON RANDALL A Director | Disposed (D) | 1.66K @ $4.26 | $7.08K |
| 2024-12-15 | CHAN YIU TUNG Director | Exercise | 1.30K | |
| 2024-12-15 | CHAN YIU TUNG Director | Disposed (D) | 1.30K @ $4.26 | $5.52K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median